No Data
No Data
12 Health Care Stocks Moving In Thursday's After-Market Session
Senti Biosciences to Host Conference Call on SENTI-202 Phase 1 Clinical Data Ahead of AACR Annual Meeting
Senti Biosciences Releases KOL Segment Featuring Dr. Stephen Strickland on Advances in Acute Myeloid Leukemia Research
Senti Bio Participates in a Virtual Investor KOL Connect Segment
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
Senti Bio Bolsters Scientific Advisory Board With Appointment of James B. Trager, Ph.D.